37.68
price up icon6.56%   2.32
after-market 시간 외 거래: 37.87 0.19 +0.50%
loading

Nektar Therapeutics 주식(NKTR)의 최신 뉴스

pulisher
02:21 AM

Nektar Therapeutics Stock Defies Short Sellers with Sharp Rally - AD HOC NEWS

02:21 AM
pulisher
Jan 15, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar TherapeuticsNKTR - Your Wyoming Link

Jan 15, 2026
pulisher
Jan 13, 2026

Nektar Therapeutics (NASDAQ:NKTR) Stock Price Down 6.7%What's Next? - MarketBeat

Jan 13, 2026
pulisher
Jan 12, 2026

History Review: Is Nektar Therapeutics stock a value trapTrade Entry Summary & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 12, 2026

Nektar Therapeutics Q3 Loss Narrower Than Expected, Revenues Rise Y/Y - MSN

Jan 12, 2026
pulisher
Jan 11, 2026

Why the JP Morgan conference is important — but not make-or-break - statnews.com

Jan 11, 2026
pulisher
Jan 10, 2026

BTIG maintains Nektar Therapeutics (NKTR) buy recommendation - MSN

Jan 10, 2026
pulisher
Jan 10, 2026

Ignore Nektar Therapeutics stock in 2026 and load up on this one instead - MSN

Jan 10, 2026
pulisher
Jan 10, 2026

Will Nektar Therapeutics (ITH0) stock outperform energy sector in 2025Trade Performance Summary & Step-by-Step Trade Execution Guides - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

Nektar Therapeutics (NKTR) price target increased by 14.31% to 109.43 - MSN

Jan 10, 2026
pulisher
Jan 09, 2026

Q1 EPS Estimate for Nektar Therapeutics Raised by Analyst - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Nektar Therapeutics (NASDAQ:NKTR) Shares Pass Above 200 Day Moving AverageHere's What Happened - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

NKTR Stock Price, Forecast & Analysis | NEKTAR THERAPEUTICS (NASDAQ:NKTR) - Chartmill

Jan 09, 2026
pulisher
Jan 09, 2026

Here's why Nektar Therapeutics (NKTR) is a great momentum stock to buy - MSN

Jan 09, 2026
pulisher
Jan 08, 2026

Nektar leaps a third on abuse-deterrent analgesic data - The Pharma Letter

Jan 08, 2026
pulisher
Jan 08, 2026

Why Nektar Therapeutics stock remains on watchlists2025 Macro Impact & Advanced Swing Trade Entry Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Can Nektar Therapeutics stock sustain institutional interestJuly 2025 Earnings & Accurate Intraday Trading Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why analysts remain bullish on Nektar Therapeutics stockTrend Reversal & Weekly High Return Stock Forecasts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Nektar Therapeutics stock a dividend growth opportunity2025 Trade Ideas & Precise Trade Entry Recommendations - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Nektar Therapeutics stock a buy in volatile marketsJuly 2025 Market Mood & High Accuracy Trade Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance

Jan 08, 2026
pulisher
Jan 08, 2026

Nektar Therapeutics Shares Rise After Positive Asthma Data in Atopic Dermatitis Patients - MSN

Jan 08, 2026
pulisher
Jan 08, 2026

Nektar promotions promised to drive growth of I-O pipeline - The Pharma Letter

Jan 08, 2026
pulisher
Jan 07, 2026

Portfolio Shifts: Why Nektar Therapeutics ITH0 stock trades below fair valueJuly 2025 Trends & Expert Approved Trade Ideas - moha.gov.vn

Jan 07, 2026
pulisher
Jan 07, 2026

Nektar TherapeuticsCommon Stock (NQ: NKTR - FinancialContent

Jan 07, 2026
pulisher
Jan 07, 2026

How The Narrative Around Nektar Therapeutics (NKTR) Is Shifting With Rezpeg Data And Litigation Risks - Yahoo Finance

Jan 07, 2026
pulisher
Jan 05, 2026

Nektar Therapeutics Too Risky? This Biotech Stock Offers a Safer Bet - NAI500

Jan 05, 2026
pulisher
Jan 05, 2026

Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead - AOL.com

Jan 05, 2026
pulisher
Jan 05, 2026

New anxiety medications are in the pipeline for 2026 - AOL.com

Jan 05, 2026
pulisher
Jan 05, 2026

FDA Leadership Stability Urged as Rare Disease Drug Approval Policies Expected to Show Results by 2026 - geneonline.com

Jan 05, 2026
pulisher
Jan 02, 2026

Nektar Therapeutics: Can a Beaten-Down Biotech Still Surprise Wall Street? - AD HOC NEWS

Jan 02, 2026
pulisher
Jan 01, 2026

What drives Nektar Therapeutics stock priceFinancial Sector Performance & Free Unlock Portfolio Growth - earlytimes.in

Jan 01, 2026
pulisher
Jan 01, 2026

How Nektar Therapeutics stock reacts to global recession fearsGrowth vs. Value Investing & Optimize Entry & Exit With Smart Signals - bollywoodhelpline.com

Jan 01, 2026
pulisher
Jan 01, 2026

Drugs to Watch in 2026 - Dermatology Times

Jan 01, 2026
pulisher
Jan 01, 2026

Nektar Therapeutics Stock Analysis and ForecastStock Screening Results & Outstanding Return Portfolio - earlytimes.in

Jan 01, 2026
pulisher
Jan 01, 2026

Moody Aldrich Partners LLC Buys 28,304 Shares of Nektar Therapeutics $NKTR - MarketBeat

Jan 01, 2026
pulisher
Dec 31, 2025

Top 10 skin disorder stories of 2025 - Healio

Dec 31, 2025
pulisher
Dec 30, 2025

Simplify Asset Management Inc. Buys 35,176 Shares of Nektar Therapeutics $NKTR - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Nektar Therapeutics (NASDAQ:NKTR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 30, 2025
pulisher
Dec 29, 2025

Aug Wrap: Why Nektar Therapeutics stock could rally in 2025Earnings Growth Summary & Risk Adjusted Buy/Sell Alerts - moha.gov.vn

Dec 29, 2025
pulisher
Dec 28, 2025

Dermatology Times 2025 Year in Review: Atopic Dermatitis - Dermatology Times

Dec 28, 2025
pulisher
Dec 26, 2025

Brain Implants for Mental Health and Chinese Competition Expected to Shape BCI Advancements by 2026 - geneonline.com

Dec 26, 2025
pulisher
Dec 26, 2025

The Zacks Analyst Blog Mineralys, Lyell, Insmed and Nektar - sharewise.com

Dec 26, 2025
pulisher
Dec 25, 2025

More Unpleasant Surprises Could Be In Store For Nektar Therapeutics' (NASDAQ:NKTR) Shares After Tumbling 25% - simplywall.st

Dec 25, 2025
pulisher
Dec 24, 2025

4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow - Finviz

Dec 24, 2025
pulisher
Dec 23, 2025

Nektar Therapeutics (NKTR) CEO reports RSU and stock option grants - Stock Titan

Dec 23, 2025
$32.25
price down icon 4.73%
$106.21
price up icon 0.92%
$120.28
price down icon 2.43%
$109.00
price up icon 2.76%
$161.42
price up icon 1.35%
biotechnology ONC
$338.19
price down icon 0.03%
자본화:     |  볼륨(24시간):